FDA Approved: IMATINIB MESYLATE — Original Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approval of Teva's Imatinib Mesylate Original Application under ANDA204285 for a generic Imatinib product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Chronic Myeloid Leukemia
• Dermatofibrosarcoma Protuberans
• Eosinophilic Leukemia
• Gastrointestinal Stromal Tumor
• Hypereosinophilic Syndrome

Drugs mentioned

• Imatinib mesylate (Imatinib)

Snippet

ORIG AP for IMATINIB MESYLATE (IMATINIB MESYLATE)